Glutamate directly activates NMDA receptors on presynaptic inhibitory interneurons and 30 enhances GABA release, altering the excitatory-inhibitory balance within a neuronal circuit. 31
Summary 29
Glutamate directly activates NMDA receptors on presynaptic inhibitory interneurons and 30 enhances GABA release, altering the excitatory-inhibitory balance within a neuronal circuit. 31
However which class of NMDA receptors are involved in the detection of glutamate spillover is 32 not known. GluN2D subunit-containing NMDA receptors are ideal candidates as they exhibit a 33 high affinity for glutamate. We now show that cerebellar stellate cells express both GluN2B and 34
GluN2D NMDA receptor subunits. Genetic deletion of GluN2D subunits prevented a 35 physiologically relevant stimulation-induced, lasting increase in GABA release from stellate cells 36 (inhibitory LTP, I-LTP). NMDA receptors are tetramers composed of two GluN1 subunits 37 associated to either two identical subunits (di-heteromeric receptors) or to two different subunits 38 (tri-heteromeric receptors).To determine whether tri-heteromeric GluN2B/2D NMDA receptors 39
mediate I-LTP we tested the prediction that deletion of GluN2D converts tri-heteromeric 40
GluN2B/2D to di-heteromeric GluN2B NMDA receptors. We find that prolonged stimulation 41 rescued I-LTP in GluN2D knockout mice, and this was abolished by GluN2B receptor blockers 42 that failed to prevent I-LTP in wild type mice. Therefore NMDA receptors that contain both 43
GluN2D and GluN2B mediate the induction of I-LTP. Because these receptors are not present 44 in the soma and dendrites, presynaptic tri-heteromeric GluN2B/2D NMDA receptors in inhibitory 45 interneurons are likely to mediate the cross-talk between excitatory and inhibitory transmission. Analog signals were filtered at 2 or 10 kHz and digitized at 10 kHz (Multiclamp 700A, Axon 127 Instruments). Series resistance was monitored throughout the recordings and if this changed by 128 more than 20%, the recordings were discarded. All synaptic and dendritic currents were 129 recorded at near physiological temperature (33 -37°C; except for the data in Fig 1) while single 130 channel currents in outside-out patches were recorded at room temperature to reduce noise. 131
Long-term potentiation of inhibitory transmission (I-LTP). Miniature inhibitory synaptic 132
currents (mIPSCs) were recorded in stellate cells. Cells were voltage clamped at -30 mV in the 133 presence of 0.5 µM TTX in aCSF, using borosilicate electrodes (6-8 MΩ) filled with a low 134 chloride pipette solution (in mM: 120 Cs acetate, 0.4 MgCl 2 , 0.1 CaCl 2 , 2.5 MgATP, 0.4 NaGTP, 135 1.5 NaATP, 10 Cs-EGTA, 5 QX-314 and 10 HEPES, pH 7.3). After obtaining a stable recording 136 for at least 15 minutes, TTX was washed out for 20 min. Parallel fibers were then stimulated 137 with a parallel bipolar electrode (150 µm spacing) that was placed across the molecular layer 138 about 200 µm from the recording electrode. The strength of the stimulation ranged from 5 to 50 139 V with a duration of 200 µs and was adjusted to evoke NMDA receptor currents at +40 mV in 140 response to a single burst stimulation (4 stimuli at 100 Hz). I-LTP was then induced using 5 or 141 15 repeated trains of burst stimulation (repeated every second) while the postsynaptic cell was 142
voltage-clamped at -60 mV. These are physiological relevant stimulation protocols since 143 sensory stimulation in vivo evokes a burst of action potentials at ∼80 Hz in granule cells 144 (Chadderton et al., 2004; Wilms and Häusser, 2015) , the axons of which innervate stellate cells. 145
Axonal calcium transients in stellate cells elicited by activation of presynaptic NMDA receptors 146 reach a peak value at ~400 ms after glutamate uncaging and remain high at 800 ms (Fig 5, Fig  147   2Ad ; (Rossi et al., 2011) . Thus repeated stimulation of PFs with a 960 ms inter-train interval is 148 expected to lead to a sustained increase in presynaptic calcium levels. Immediately after 149 parallel fiber stimulation TTX was re-introduced into the aCSF and recordings of mIPSCs were 150 started within 2 minutes. 151
Dendritic NMDA receptor currents. Dendritic NMDA receptor-mediated currents were 152 recorded using a Cs-based pipette solution (in mM: 140 CsCl, 2 NaCl, 10 HEPES, 4 Mg-ATP, 5 153 respectively. The evoked currents were recorded for 15 min to obtain a stable baseline before 165 application of NMDA receptor inhibitors. 166
Dendritic AMPA currents and paired pulse ratio. AMPA receptor-mediated EPSCs were 167 recorded using the Cs-based internal solution and evoked by stimulating PFs with a monopolar 168 stimulating electrode in the presence of 10 µM CPP (to block NMDA receptor currents). AMPA 169 currents were recorded at -60 mV following 2 consecutive PF stimulations (50 Hz) repeated 170 every 3 seconds. Typical stimulation intensity was 2 to 5 V with a duration of 200 µs. The 171 paired-pulse ratio of average EPSCs (typically 100 to 150 events) at the PF-stellate cell 172 synapse was calculated as the ratio of the amplitude of the second EPSC (EPSC 2 ) over the first 173
(EPSC 1 ). 174
Somatic NMDA receptor currents in outside-out patches. Recordings were obtained in a 175 magnesium-free aCSF that contained 0.5 µM TTX, 5 µM NBQX, 10 µM SR-95531 and 0.5 µM 176 strychnine. Somatic outside out patches were voltage-clamped at -60 mV using borosilicate 177 electrodes (7-15 MΩ) filled with a cesium fluoride-based pipette solution (in mM: 95 CsF, 35 178
CsCl, 2 NaCl, 1 CaCl2, 4 MgATP, 10 Cs-EGTA, 1 QX-314, 5 TEA and 10 HEPES, pH 7.3). If 179 recordings did not contain any spontaneous channel openings, the aCSF was supplemented 180 with 10 µM glycine and 10 µM NMDA. Currents at 0 or -100 mV were also recorded to ensure 181 that the reversal potential was 0 mV. The NMDA-evoked currents were recorded for 10 min to 182 obtain a stable baseline (control period) and then in the presence of a NMDA receptor inhibitor 183 for at least 10 min. Following washout of each inhibitor, NMDA-evoked currents returned to 184 control levels (% change: CPP, 4 ±10%, n = 16; Ifenprodil, -16 ± 12%, n = 5; PPDA, -5 ± 8%; n 185 = 7, P > 0.05 for all drugs, washout vs control). For analysis, current traces were re-sampled at 186 10 kHz and filtered at 1 kHz. Events of more than 0.6 pA and lasting more than 2 filter rise times 187 (332 µs) were then selected over a 1 minute period and charge transfer was calculated. randomly to the different experimental conditions. All values are expressed as mean ± SEM and 212 a P value < 0.05 was considered as significant. All tests were performed on primary data (not 213 normalized). Normality and equality of the variances were assessed and statistical tests were 214 chosen accordingly. These mostly included one-way or two-way ANOVA with repeated 215 measurements (except for figure 11) GluN2D knockout mice (Ikeda et al., 1995) . We found that deletion of GluN2D subunits 229 accelerated the decay kinetics of dendritic NMDA receptor currents ( Fig 1A) . charge transfer of NMDA-currents decreased by ∼60% in mutant mice (Fig 1D) . Furthermore 0.1 234 µM PPDA, which blocks GluN2D-containing NMDA receptors, reduced the NMDA-evoked 235 currents in outside-out patches from wild type stellate cells by 57 ± 6 % (n = 5; P < 0.01; Fig 1E  236 and F). These results indicate that GluN2D-containing receptors mediate the dendritic and 237 somatic NMDA receptor currents in stellate cells. 238
240
We next investigated the contribution of GluN2B-containing NMDA receptors to dendritic 241 NMDA receptor currents in wild type mice. At 33-37°C 3 µM Ifenprodil inhibited the amplitude of 242 dendritic NMDA receptor currents by 32 ± 6 % (pre 427 ± 103; Ifenprodil 291 ± 89 pA; n = 7; P < 243 0.001) and reduced the charge transfer by 20 ± 7 % (P < 0.001). Thus GluN2B receptors are 244 present in the dendrites of stellate cells, consistent with a report that GluN2B but not GluN2A-245 containing NMDA receptors mediate dendritic NMDA receptor currents in rat stellate/basket 246 cells (Bidoret et al., 2015) . Ifenprodil also prolonged the decay time constant in wild type mice 247 from 163 ± 10 ms to 201 ± 15 ms (Fig 2A and B ; P < 0.05), consistent with the presence of 248 GluN2D-containing NMDA receptors. Furthermore we found that 3 µM ifenprodil inhibited 249 NMDA-evoked currents in outside-out patches from wild type stellate cells by 47 ± 9 % (n = 5; P 250 < 0.01; Fig 2C and 2D) . A marked increase in the blockade of NMDA receptor currents by 251 ifenprodil in GluN2D KO mice to ~90% inhibition, compared to WT mice indicates that somatic 252 NMDA receptor currents are largely mediated by GluN2B and GluN2D receptors. To test whether this change was due to reduced glutamate release from PFs in mutant 271 mice, we stimulated PFs with two consecutive stimuli and EPSCs were recorded at -60 mV in 272 the presence of CPP (10 µM) and picrotoxin (100 µM) to block NMDA and GABA receptors, 273 respectively. The paired pulse ratio of evoked EPSCs did not change in the GluN2D knockout 274 mice (WT 1.9 ± 0.2, n = 7; GluN2D KO 2.0 ± 0.2, n = 6; Fig 4A) , indicating that the probability of 275 glutamate release from PFs in mutant mice was not altered. Furthermore, mIPSC frequency 276 was not altered in GluN2D knockout mice (WT 2.2 ± 0.3 Hz, n = 49; GluN2D KO 2.1 ± 0.3 Hz, n 277 = 36; Fig 4B) , suggesting that basal spontaneous GABA release was also unaffected. Thus 278 deletion of GluN2D subunits prevents the NMDA receptor-dependent, lasting increase in GABA 279 release induced using a threshold stimulation protocol. 280
GluN2D sets a low threshold for induction of I-LTP 281
Tri-heteromeric receptors are composed of two GluN1 and two distinct GluN2 subunits and are 282 thought to be the majority of the native NMDA receptors in the hippocampus (Rauner and Köhr, 283 2011). NMDA receptors that contain both GluN2B and GluN2D subunits have been described in 284 cerebellar Golgi cells and substantia nigra dopaminergic neurons (Brickley et these receptors can be activated at more hyperpolarized potentials than di-heteromeric GluN2B 290 (di-GluN2B) receptors and generate a larger current than di-heteromeric GluN2D (di-GluN2D) 291
receptors. Prominent GluN2A/B staining was observed in the axonal terminals of cerebellar 292 basket cells (Petralia et al., 1994) . This raises the possibility that tri-GluN2B/2D NMDA 293 receptors could be present in axons and induce I-LTP in wild type mice. 294
Deletion of GluN2D would convert a tri-heteromeric GluN2B/2D NMDAR to di-GluN2B 295 receptor. Because GluN2D-Rs have a higher affinity for glutamate than GluN2B-Rs, we 296 predicted that prolonging PF stimulation would increase the likelihood of activation of low affinity 297
NMDARs by spillover glutamate and thus rescue I-LTP in GluN2D knockout mice. To test this 298 possibility we increased the PF stimulation to 15 trains. Thus the presence of GluN2D in NMDA receptors lowered the threshold for induction of I-LTP. 308
We next investigated the possibility that tri-GluN2B/2D NMDA receptors induce I-LTP in 309 stellate cells from wild type mice. Deletion of GluN2D is predicted to alter the tri-GluN2B/2D 310 receptors to di-GluN2B receptors which contain two GluN2B subunits. Ifenprodil at 3 µM has 311 been shown to inhibit di-GluN2B receptors, but not tri-GluN2B/2D NMDA receptors (Brickley et 312 al., 2003) . Application of ifenprodil (3 µM) did not block the 15 train PF-stimulation-induced 313 increase in mIPSC frequency (95 ± 37 %; pre-stim 1.2 ± 0.3; post-stim 2.4 ± 0.8 Hz; n = 6; P < 314 0.05; Fig 6A, C and E) and did not alter the basal mIPSC frequency (Fig 4D) in wild type mice. 315
Thus di-GluN2B receptors are not necessary for the induction of I-LTP. We therefore 316 determined whether activation of di-GluN2B receptors triggered I-LTP in GluN2D knockout 317 mice. In contrast to wild type mice, application of the selective antagonists ifenprodil (3 µM) and 318 RO 04-5595 (5 µM) during a 15 train PF stimulation protocol completely prevented the induction 319 of I-LTP (pre-stim 2.2 ± 0.8; post-stim 1.6 ± 0.6 Hz; Fig 6B-E) in mutant mice. These results 320
indicate that activation of di-GluN2B receptors induces a lasting increase in GABA release only 321 in mutant mice but not in wild type mice (Fig 6E) . Therefore tri-GluN2B/2D receptors in wild type 322 mice are responsible for the induction of I-LTP. results, however, show that GluN2B blockers inhibited dendritic NMDA receptors, but failed to 338 block I-LTP (Fig 2E and 6A) . Second inhibitors that block I-LTP should also inhibit NMDA 339 receptor currents in the soma or dendrites. To address this issue we tested the ability of two 340 inhibitors to block tri-GluN2B/2D-Rs and determined whether these inhibitors prevented the 341 induction of I-LTP. 342
First, PPDA exhibits a moderate preference for GluN2C and GluN2D over GluN2A and GluN2B 343 recombinant receptors. Thus PPDA at 0.1 µM is reported to preferentially block GluN2C/D-344 containing NMDA receptors (Feng et al., 2004) . To determine whether 0.1 µM PPDA inhibits 345 native GluN2D-containing receptors we took advantage of the well characterized expression of 346 tri-GluN2B/2D (and di-GluN2B) receptors in P7-10 Golgi cells, and di-GluN2D receptors in 347
Purkinje cells (Misra et al., 2000; Brickley et al., 2003) . We excised outside-out patches from 348 somata of these neurons and evoked NMDAR currents by application of NMDA and glycine. 349
Renzi et al (2007) have shown that ~25% of Purkinje cell patches also have large conductance 350 NMDA receptor currents due to GluN2A and 2B receptors. However such currents were not 351 detected in our patches and therefore NMDA receptor currents in these patches were mainly 352 mediated by di-GluN2D receptors. We found that 0.1 µM PPDA inhibited NMDA-evoked 353 currents in outside-out patches excised from Golgi cells (-45 ± 13 %; n = 5; P < 0.01; Fig 7B and  354   D) . PPDA also reduced the somatic single channel currents mediated via di-GluN2D NMDA 355 receptors in Purkinje cells (-59 ± 13 %; n = 5; P < 0.05; Fig 7C and D) . In contrast PPDA at 0.1 356 µM did not inhibit somatic currents mediated by di-GluN2B receptors in stellate cells from P18 357
GluN2D knockout mice (3 ± 9 %; n= 6; P > 0. (Fig 4D) . This 363 result is consistent with the idea that GluN2D receptors are critically involved in the induction of 364
I-LTP in stellate cells. 365
Second, a low concentration of CPPene has been shown to inhibit recombinant tri-GluN2B/2D 366 receptors (IC 50 = 0.06 µM), di-GluN2B receptors (IC 50 = 0.14 µM), but not di-GluN2D receptors 367 (IC 50 = 1.8 µM) (Buller and Monaghan, 1997) . We next tested whether 0.2 µM CPP, the parent 368 compound of D-CPPene, blocked tri-GluN2B/2D, but not di-GluN2D, and determined its effects 369 on di-GluN2B receptors in neurons. CPP at 0.2 µM did not inhibit somatic GluN2B NMDA 370 receptor currents in stellate cells from GluN2D knockout mice (4 ± 6 %; Fig 8A and D) , which 371 could be due to a reduced inhibitory potency of CPP relative to CPPene (Lowe et al., 1990) . 372
Application of 0.2 µM CPP reversibly inhibited NMDA-evoked currents mediated via tri-373
GluN2B/2D NMDA receptors in outside-out patches from the somata of Golgi cells (-54 ± 8 %; n 374 = 7; P < 0.01; washout: -6 ±12%; n = 5; Fig 8B and D) , but did not block NMDA receptor 375 currents in patches from Purkinje cells (7 ± 9 %; n = 6; P > 0.05; Fig 8C and D) . Thus in 376 cerebellar neurons CPP at 0.2 µM blocks tri-GluN2B/2D NMDA receptors rather than di-GluN2D 377 or di-GluN2B receptors. 378
If tri-GluN2B/2D NMDA receptors are involved in I-LTP induction, a low concentration of 379 CPP should block I-LTP. Indeed we found that application of 0.2 µM CPP during PF stimulation 380 prevented the induction of I-LTP in wild type mice (pre-stim 1.1 ± 0.4; post-stim 0.8 ± 0.3 Hz; n = 381 8; P > 0.05; Fig 9A-B) , but did not modify basal GABA release (Fig 4D) . This is consistent with 382 the idea that tri-GluN2B/2D receptors are required to induce I-LTP in stellate cells. 383
Our
Do I-LTP inhibitors also block somato-dendritic NMDA receptor currents? 390
The dendritic model in which activation of dendritic NMDA receptors is necessary for the 391 induction of presynaptic I-LTP predicts that inhibitors that block I-LTP should also inhibit NMDA 392 receptor currents in the soma or dendrites. We therefore determined the effect of a low 393 concentration of CPP on somato-dendritic NMDA receptor currents in wild type mice. 394
Application of CPP at 0.2 µM did not block the NMDA receptor current in somatic 395
patches from stellate cells (1 ± 4 %; n= 5; Fig 10A and B) . Because a low concentration of CPP 396 inhibits NMDA-evoked currents in outside-out patches from cerebellar Golgi cells that express 397 tri-GluN2B/2D receptors, these receptors are unlikely to be present in the somata of stellate 398
cells. 399
We then stimulated parallel fibers at 100 Hz (4 stimuli) to activate dendritic NMDA 400 receptors at 33-37°C and found that 0.2 µM CPP had no effect on the amplitude of dendritic 401 NMDA receptor currents (pre 463 ± 85; CPP 412 ± 79 pA; n = 5) or total charge transfer (3 ± 3 402 %). The decay time also remained unaltered (pre 219 ± 17; CPP 234 ± 22 ms; Fig 10C-F) . Thus 403 NMDA receptors that are sensitive to a low concentration of CPP, including tri-GluN2B/2D 404 receptors, are absent from the somata and dendrites of stellate cells. The IC 50 of CPP for 405 NMDAR subtypes may differ between somatic and dendritic receptors, which were activated by 406 application of NMDA and spillover glutamate, respectively. We therefore compared the effects 407 of 0.2 µM CPP on I-LTP with that on dendritic NMDA receptors, since in the dendritic model, 408 activation of dendritic NMDA receptor is responsible for the induction of I-LTP. Because 0.2 µM 409 CPP completely prevented the induction of I-LTP, but failed to block dendritic currents (Fig 9A  410 and B), the tri-GluN2B/2D receptors that are responsible for the induction of I-LTP are unlikely 411 to be located in the somata and dendrites of stellate cells. Consistent with this idea, we found no 412 correlation between the degree of I-LTP and the total charge transfer of the slow component of 413 the dendritic currents recorded at -60 mV during PF stimulation (Fig 11) . PPDA reduced the charge transfer of somatic NMDAR currents. *, P < 0.05; **, P < 0.01. 520 thus GluN2B receptors mediate NMDA receptor currents. In GluN2D KO mice (right) ifenprodil 531 nearly abolished the NMDA-evoked currents from stellate cells. F. The total charge transfer was 532 markedly reduced in wild-type and abolished in GluN2D KO mice. NMDA receptor currents are 533 mediated by a pure population of di-GluN2B NMDA receptors in mutant mice. *, P < 0.05; **, P 534 < 0.01; ***, P < 0.001. 535 with two consecutive stimuli in wild type (left) and GluN2D knockout mice (right). Bottom, the 556 paired-pulse ratio of EPSCs at the PF-stellate cell synapse (the ratio of amplitude of EPSC 2 / 557 EPSC 1 ) was not modified in GluN2D KO mice (wild-type n = 7, GluN2D KO n = 6), indicating 558 that the release probability of glutamate from parallel fibers was not altered. stimulation (n = 6). Light gray area shows the mean ± SEM of mIPSC frequency after PF 593 stimulation without GluN2B antagonist in wild type mice (from Fig 5A) for comparison. 
B. In 594
GluN2D KO animals, I-LTP was blocked by GluN2B antagonists (3 µM ifenprodil or 5 µM RO 595 04-5595, n = 8). For comparison the light gray area shows the mean ± SEM of mIPSC 596 frequency after PF stimulation without GluN2B antagonist in GluN2D KO mice (from Fig 5B) . C -597
D. Mean mIPSC frequency (C.) and amplitude (D.) in individual cells following 15 trains of PF 598
stimulation in wild type and mutant mice. E. Summary of the effects of GluN2B antagonists on 599 the long-lasting increase in mIPSC frequency induced by 15 trains of PF stimulation. GluN2B 600 antagonists effectively blocked I-LTP only in GluN2D KO mice, suggesting that activation of di-601 GluN2B receptors induced a lasting increase in GABA release in mutant mice. Ifenprodil failed 602 to prevent I-LTP in wild type mice and thus NMDA receptors that contain both GluN2D and 603
GluN2B subunits are responsible for the induction of I-LTP in wild type mice. *, P < 0.05. 604 (Fig 5A) . F. Application of 0.1 µM PPDA during PF stimulation 619 abolished I-LTP (n = 7). For drug effects: *, P < 0.05, **, P < 0.01, for the interaction between 620 drugs and cell types #, P < 0.05. 621 GluN2B/2D receptors (Fig 5 and 6 ), is not triggered by a somato-dendritic depolarization. 658 
